Taiwan FDA registration d0b7755a95c6a0315121671503c0ce09
"Leica" Surgipath Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile)
TW: "徠卡"瑟基帕思體外診斷用的細胞冷凍設備及反應劑 (未滅菌)
Taiwan·Risk Class 1·MD·LEICA BIOSYSTEMS RICHMOND INC.·Registered Aug 02, 2013 – Aug 02, 2023ExpiredRegistration details
- Analysis ID
- d0b7755a95c6a0315121671503c0ce09
- License Form
- Ministry of Health Medical Device Import No. 013257
- Customs Code
- DHA09401325705
Company information
- Manufacturer
- LEICA BIOSYSTEMS RICHMOND INC.
- Manufacturer Country
- United States
- Authorized Representative
- BOND BIOTECH, INC.
Product details
- Intended Use
- Limited to the first level identification range of cell cryogenic equipment and reactants (B.9225) for in vitro diagnosis of medical device management methods.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9225 Cell cryogenic equipment and reactants for in vitro diagnostics
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 02, 2013
- Expiry Date
- Aug 02, 2023
About this record
Access comprehensive regulatory information for "Leica" Surgipath Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d0b7755a95c6a0315121671503c0ce09 and manufactured by LEICA BIOSYSTEMS RICHMOND INC.. The authorized representative in Taiwan is BOND BIOTECH, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices